bioresorbable scaffold

Original Contribution

Drug-Eluting Resorbable Magnesium Scaffold Implantation in ST-Segment Elevation Myocardial Infarction: A Pilot Study

04/15/2018

Quentin de Hemptinne, MD^1*; Fabien Picard, MD, MSc^2*; Rachid Briki, MD¹; Ahmad Awada, MD¹; Paul-Ga√´l Silance, MD¹; Dariouch Dolatabadi, MD¹; Nadia Debbas, MD, PhD^1*; Philippe Unger, MD, PhD^1*

Quentin de Hemptinne, MD1*; Fabien P...

An assessment of the feasibility and short-term clinical outcomes associated with resorbable magnesium scaffold implantation in the setting of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

An assessment of the feasibility...

04/15/2018

Journal of Invasive Cardiology

Original Contribution

Twelve-Month Outcomes With a Bioresorbable Everolimus-Eluting Scaffold: Results of the ESHC-BVS Registry at Two Australian Centers

11/15/2015

Daniel Robaei, MBBS^1,2,3; Liam Back, MBBS¹; Sze-Yuan Ooi, MD^1,3; Mark Pitney, MBBS^1,2,3; Nigel Jepson, MBBS^1,3

Daniel Robaei, MBBS1,2,3; Liam Back,...

The Absorb BVS is a relatively new type of coronary stent designed to provide temporary vessel scaffolding following percutaneous coronary intervention. We report 12-month clinical data on the Absorb BVS from a real-world registry in order to...

The Absorb BVS is a relatively...

11/15/2015

Journal of Invasive Cardiology